Adequan i.m. by is a Animal medication manufactured, distributed, or labeled by American Regent, Inc.. Drug facts, warnings, and ingredients follow.
Polysulfated Glycosaminoglycan is chemically similar to the glycosaminoglycans in articular cartilage matrix. PSGAG is a potent proteolytic enzyme inhibitor and diminishes or reverses the pathologic processes of traumatic or degenerative joint disease which result in a net loss of cartilage matrix components. PSGAG improves joint function by reducing synovial fluid protein levels and increasing synovial fluid hyaluronic acid concentration in traumatized equine carpal and hock joints.
Practice aseptic techniques in withdrawing each dose to decrease the possibility of post-injection bacterial infections. Adequately clean and disinfect the stopper prior to entry with a sterile needle and syringe. Use only sterile needles, and use each needle only once.
The vial stopper may be punctured a maximum of 10 times.
The recommended dose of Adequan® i.m. Multi-Dose in horses is 500 mg every 4 days for 28 days intramuscularly. The injection site must be thoroughly cleansed prior to injection. Do not mix Adequan® i.m. Multi-Dose with other drugs or solvents.
Animal Safety studies utilizing Adequan® i.m. Multi-Dose were not performed. Safety studies were conducted in horses using the single dose formulation. Doses as high as 2,500 mg were administered intramuscularly to 6 horses twice a week for 12 weeks. This dosage is 5 times the recommended dosage and 3 times the recommended therapeutic regimen. Clinical observations revealed no soreness or swelling at the injection site or in the affected joint. No animal had any clinical or laboratory evidence of toxicity.
Store at 20°-25°C (68°-77°F); excursions permitted to 15°-30°C (59°-86°F) (See USP Controlled Room Temperature). Avoid prolonged exposure to temperatures ≥ 40°C (104°F).
Use within 28 days of first puncture and puncture a maximum of 10 times. Dispose of spent needles in accordance with all federal, state and local environmental laws.
Adequan® i.m. Multi-Dose solution, 5,0000 mg/50 mL (100 mg/mL) in 50 mL multi-dose glass vials.
NDC: 10797-959-01 50 mL Multi-Dose Vials Packaged 1 vial per box
AMERICAN REGENT, INC.
ANIMAL HEALTH
Shirley, NY 11967
(631) 924-4000
800-458-0163
Made in U.S.A.
IN959
Rev. 1/19
MG# 28493
NADA #140-901, Approved by FDA
NDC: 10797-959-01
Adequan® i.m. Multi-Dose
(POLYSULFATED GLYCOSAMINOGLYCAN)
100 mg/mL 50 mL Preserved Multiple Dose Vial
CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
For Intramuscular Use in Horses Only. Not for Intra-Articular Use.
Use within 28 days of first puncture.
WARNING: Do not use in horses intended for human consumption.
Store at 20°-25°C (68°-77°F). Avoid prolonged exposure to temperatures ≥ 40°C (104°F).
See package insert for full directions.
AMERICAN REGENT, INC.
ANIMAL HEALTH
Shirley, NY 11967
NADA 140-901, Approved by FDA
Rev. 1/19
NDC: 10797-959-01
Adequan® i.m.
(POLYSULFATED GLYCOSAMINOGLYCAN)
MULTI-DOSE
100 mg/mL
(5000 mg/50 mL)
PSGAG injection for intramuscular use in horses only. Not for intra-articular use.
Contains one 50 mL Preserved Multiple Dose Vial
AMERICAN REGENT, INC.
ANIMAL HEALTH
Shirley, NY 11967
(800) 458-0163
NADA 140-901, Approved by FDA
ADEQUAN I.M.
polysulfated glycosaminoglycan injection, solution |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - American Regent, Inc. (002033710) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
---|---|---|---|
American Regent, Inc. | 002033710 | ANALYSIS, MANUFACTURE, STERILIZE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ADEQUAN I.M. 98204778 not registered Live/Pending |
American Regent, Inc. 2023-09-29 |